{"slideshow_credits": null, "snippet": "The finding contradicts critics&#8217; predictions that pre-exposure prophylaxis, or PrEP, would lead to less condom use and more H.I.V. infections.", "abstract": "Study published by Kaiser Permanente, San Francisco's largest private health insurer, in journal Clinical Infectious Diseases finds that not one of 657 clients given pre-exposure prophylaxis became infected with HIV over period of more than two years; subjects were given two-drug combination called Truvada; findings contradict concerns of critics, who said PrEP could lead to more HIV infections.", "section_name": "Health", "print_page": "22", "document_type": "article", "byline": {"person": [{"lastname": "McNEIL", "qualifier": "Jr", "rank": 1, "firstname": "Donald", "role": "reported", "organization": "", "middlename": "G."}], "original": "By DONALD G. McNEIL Jr"}, "web_url": "http://www.nytimes.com/2015/09/03/health/insurer-says-clients-on-daily-pill-have-stayed-hiv-free.html", "lead_paragraph": "The finding contradicts critics&#8217; predictions that pre-exposure prophylaxis, or PrEP, would lead to less condom use and more H.I.V. infections.", "headline": {"main": "Insurer Says Clients on Daily Pill Have Stayed H.I.V.-Free", "print_headline": "Insurer Says Clients on a Daily Pill Have Stayed Free of H.I.V. for Two Years"}, "_id": "55e7708938f0d80b7eeea5fc", "word_count": "738", "multimedia": [{"height": 126, "url": "images/2015/09/03/science/03hiv/03hiv-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/09/03/science/03hiv/03hiv-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/09/03/science/03hiv/03hiv-articleLarge.jpg", "legacy": {"xlarge": "images/2015/09/03/science/03hiv/03hiv-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/09/03/science/03hiv/03hiv-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/09/03/science/03hiv/03hiv-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-09-03T00:00:00Z", "source": "The New York Times", "news_desk": "National", "keywords": [{"name": "subject", "value": "Acquired Immune Deficiency Syndrome", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Kaiser Permanente", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Clinical Infectious Diseases (Journal)", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Truvada (Drug)", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Sexually Transmitted Diseases", "is_major": "N", "rank": "5"}, {"name": "glocations", "value": "San Francisco (Calif)", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Homosexuality and Bisexuality", "is_major": "N", "rank": "7"}, {"name": "subject", "value": "Condoms", "is_major": "N", "rank": "8"}, {"name": "persons", "value": "Volk, Jonathan E", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": null, "type_of_material": "News"}